Broadridge Financial Solutions
BR
$136.22
-1.00%
Broadridge Financial Solutions Inc. is a leading provider of investor communication and technology-driven solutions, operating primarily in the Information Technology Services sector for financial institutions including banks, broker-dealers, and asset managers. The company is a dominant market leader in its core segments of investor communications and securities processing, distinguished by its mission-critical, recurring revenue business model that creates high client switching costs. The current investor narrative is dominated by a significant stock price decline, raising questions about the durability of its growth model, potential competitive pressures, and the impact of a challenging macro environment on its financial services client base, despite its historically stable operations.…
BR
Broadridge Financial Solutions
$136.22
BR 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Broadridge Financial Solutions's 12-month outlook, with a consensus price target around $177.09 and implied upside of +30.0% versus the current price.
Average Target
$177.09
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$109 - $177
Analyst target range
Analyst coverage for Broadridge appears limited, with only 3 analysts providing estimates for revenue and EPS, and no consensus price target or recommendation data provided in the dataset. The estimated EPS average for the forward period is $13.80, with a narrow range from $13.68 to $13.98, while estimated revenue averages $8.84 billion. The lack of a broad analyst target price consensus typically indicates this is a mid-cap stock with selective institutional coverage, which can lead to higher volatility and less efficient price discovery. Recent institutional rating actions show a mixed but generally stable sentiment, with firms like DA Davidson and Needham maintaining or initiating 'Buy' ratings in early 2026, while Morgan Stanley and UBS have maintained 'Equal Weight' or 'Neutral' stances, suggesting analysts are not universally bearish despite the price collapse.
BR Technical Analysis
The stock is in a severe and sustained downtrend, with a 1-year price change of -42.13% and a 6-month decline of -39.10%. As of the latest close of $137.60, the stock is trading near the bottom of its 52-week range, approximately 49% of the way from its 52-week low of $135.98 to its high of $271.91; this positioning near multi-year lows suggests the market is pricing in significant fundamental deterioration, though it may also attract value-oriented investors. Recent momentum remains negative and aligned with the longer-term downtrend, with the stock down -7.92% over the past month and -21.08% over the past three months, indicating persistent selling pressure without signs of a meaningful reversal. Key technical support is clearly defined at the 52-week low of $135.98, while resistance is far above at the 52-week high of $271.91; a breakdown below support would signal a continuation of the bear market, while any recovery would face substantial overhead supply. The stock's beta of 0.888 indicates it has been slightly less volatile than the broader market during this period, which is notable given its steep decline versus the SPY's 1-year gain of 24.99%, highlighting significant negative relative strength of -67.12%.
Beta
0.89
0.89x market volatility
Max Drawdown
-49.0%
Largest decline past year
52-Week Range
$134-$272
Price range past year
Annual Return
-42.4%
Cumulative gain past year
| Period | BR Return | S&P 500 |
|---|---|---|
| 1m | -9.5% | -0.2% |
| 3m | -17.3% | +14.0% |
| 6m | -40.4% | +7.8% |
| 1y | -42.4% | +25.3% |
| ytd | -38.2% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BR Fundamental Analysis
Revenue growth remains positive but has shown volatility on a quarterly basis; the most recent Q2 FY2026 revenue was $1.714 billion, representing a solid 7.85% year-over-year growth, though this follows a stronger Q4 FY2025 where revenue hit $2.065 billion. Segment data indicates the business is driven by Recurring Fee Revenue ($1.070 billion), supplemented by Distribution Revenue ($553.2 million) and Event-Driven Revenue ($90.6 million), providing a stable base. The company is profitable with a net income of $284.6 million in Q2 FY2026, translating to a net margin of 16.61%, and it maintains a healthy gross margin of 27.63% for the quarter. Profitability has improved year-over-year from a net margin of 8.96% in Q2 FY2025, and the trailing twelve-month free cash flow is a robust $1.358 billion, demonstrating strong cash conversion. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.30, and the current ratio of 0.98 indicates adequate but not excessive liquidity. The company's return on equity is strong at 31.62%, and it generates substantial free cash flow, providing internal funding for dividends, share repurchases, and potential acquisitions.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.27%
Latest Quarter
Free Cash Flow
$1.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BR Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 33.90x, while the forward P/E is significantly lower at 13.22x, indicating the market expects a substantial recovery in earnings, with the forward estimate implying an EPS of approximately $13.80. Compared to sector averages, the stock's trailing P/E of 33.9x and PS ratio of 4.13x are not directly comparable without a provided industry benchmark, but the forward P/E of 13.2x suggests a more reasonable earnings multiple if forward estimates are achieved. Historically, the stock's own valuation has compressed dramatically; its current trailing P/E of 33.9x is below the recent historical high seen in Q1 FY2026 (42.12x) but above the low from Q4 FY2023 (15.08x), indicating it is in the middle of its own historical band but following a period of multiple contraction. The PEG ratio of 1.62, based on trailing metrics, suggests the stock is fairly valued relative to its historical growth, but this hinges on future growth expectations being met.
PE
33.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~113x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.5x
Enterprise Value Multiple

